Yahoo Web Search

Search results

    • Tango terminates USP1 inhibitor programme

      Tango terminates USP1 inhibitor programme

      Clinical Trials Arena via Yahoo Finance· 44 minutes ago

      Tango Therapeutics has terminated the development of its TNG348 programme after data emerged from the Phase I/II trial showing that the therapy may cause...